Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 January 2019 | Story Charlene Stanley | Photo Charlene Stanley
Michele Middle
Michelle Middle, CMO of Farmovs, looks forward to expanding their operations after the UFS acquired 100% shareholding in 2018.

In medical research, there are NO shortcuts.

The journey of a new medicine from lab to pharmacy shelf takes on average at least 10 years.

Michelle Middle’s journey from young medical graduate starting her first job at FARMOVS to becoming the company’s Chief Medical Officer, was more than twice that long. It was a journey that systematically and adequately equipped her to now Co-captain this flagship enterprise through its biggest challenge yet.

Michelle remembers how Farmovs started in 1974 as a research centre in the Department of Pharmacology. After graduating as medical doctor, she joined Farmovs in 1993, shortly before they moved to their current extensive facilities just south of the Sasol Library.

In 2000, international Clinical Research Organization (CRO) giant Parexel acquired a 70% shareholding, and the name changed to Farmovs-Parexel.

“Parexel really invested a lot in infrastructure and technology, bringing facilities here on par with the best in the world,” says Michelle.

Her own journey in medical research took her to George and later to the US and UK, where she held various international executive leadership positions in international companies.

When the UFS acquired a 100% shareholding in Farmovs earlier this year, she came full circle, as she returned to Bloemfontein to spearhead the expansion of patient studies in collaboration with the Faculty of Health Sciences.

“The opportunities we have here are really enormous,” says an excited Michelle.

“We are the only university in the country with this kind of infrastructure. Apart from our state-of-the-art bioanalytical lab, we also have facilities to accommodate close to 100 research participants. We now have 45 years’ experience in advanced medical research, plus established international clients. We can provide pharmaceutical companies with basically everything they need to develop new medicines.”

Another exciting development is that they are expanding their clinical-trial patient population next year from healthy individuals to people suffering from a host of chronic conditions.

“While they are part of our clinical trials, patients gain valuable insight in their own conditions. We also sometimes pick up underlying medical issues they were not even aware of,” says Michelle.

The 150 Farmovs staff members range from doctors and nurses, to technologists, medical writers, and managers. While not technically part of the university staff, they form a valued part of the Bloemfontein Campus community.

News Archive

Children’s author donates material for research
2012-04-04

 

Department of Afrikaans and Dutch, German and French receives more than 70 books, manuscripts and translations from Kovsie alumnus Jaco Jacobs.  
Photo: Stephen Collett
4 April 2012

The well-known children’s author and former Kovsie, Jaco Jacobs, donated more than 70 of his books, manuscripts and translations to the University of the Free State. The work will be included in the authors’ room of the Department of Afrikaans and Dutch, German and French on the ground floor of the UFS Sasol Library.

Mr. Jacobs is an award-winning author who also worked as editor of Volksblad’s youth supplement, Jip. He received the degree B.A. (Communication Science) cum laude from our university. He has been awarded, amongst others, the Alba Bouwer Prize, C.P. Hoogenhout Award, MML Prize for Literature, Elsabé Steenberg Award and eight ATKV children’s book awards.

Mr Jacobs says he hopes the donations will provide insight into the writing process. “It would be wonderful if someone could do research because youth literature is not a genre that receives a lot of attention.”

Prof. Hennie van Coller, Head of the Department of Afrikaans and Dutch, German and French, says the donation is very valuable in terms of research. He says in other parts of the world, a lot of money is paid for this type of work.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept